On the other hand, the immune clusters were the primary recipients of signaling from the tumor clusters, whereas the normal area activated various immune-related signaling pathways (including COMPLEMENT, CCL, CXCL, and IL16), which were not received by tumor clusters (Fig. 6D, E). The gene discussed is IL16; the disease is neoplasm.